Rani Therapeutics Holdings, Inc. (RANI) Social Stream



Rani Therapeutics Holdings, Inc. (RANI): $11.00

-1.00 (-8.33%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RANI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 404

in industry

Rani Therapeutics Holdings Inc (RANI) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Rani Therapeutics Holdings Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-22 5 $29 $23 $24.6 $14.1 74.47%
2021-11-23 5 $33 $23 $26.6 $14.1 88.65%
2022-03-30 5 $33 $24 $28.4 $14.1 101.42%

Over the past 31 weeks, RANI's average upside potential has been 34.07%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-10-05 5 29 23 24.6 18.00 36.67%
2021-11-22 5 29 23 24.6 26.21 -6.14%
2021-11-23 5 33 23 26.6 26.95 -1.3%
2021-12-06 5 33 24 28.4 21.80 30.28%
2022-03-30 5 33 24 28.4 13.43 111.47%

RANI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


RANI's average broker recommendation rating improved by 0 over the prior 90 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how Rani Therapeutics Holdings Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 228.22% of that group.
  • RANI has a higher number of analysts covering the stock than 83.94% of all US stocks.
  • Rani Therapeutics Holdings Inc's average analyst price target is greater than 92.43% of all US stocks.
  • In terms of how Rani Therapeutics Holdings Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 25.9% of that group.

Stocks similar to Rani Therapeutics Holdings Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RAIN, PYXS, and PVCT.

Is RANI a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4946 seconds.